HK1016508A1 - Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment... - Google Patents

Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment...

Info

Publication number
HK1016508A1
HK1016508A1 HK99101726A HK99101726A HK1016508A1 HK 1016508 A1 HK1016508 A1 HK 1016508A1 HK 99101726 A HK99101726 A HK 99101726A HK 99101726 A HK99101726 A HK 99101726A HK 1016508 A1 HK1016508 A1 HK 1016508A1
Authority
HK
Hong Kong
Prior art keywords
flupirtine
prophylaxis
impairment
therapy
diseases associated
Prior art date
Application number
HK99101726A
Other languages
English (en)
Inventor
Gabriela Pergande
Werner E G Mueller
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Publication of HK1016508A1 publication Critical patent/HK1016508A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK99101726A 1995-11-07 1999-04-21 Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment... HK1016508A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19541405A DE19541405A1 (de) 1995-11-07 1995-11-07 Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
PCT/DE1996/002009 WO1997017072A2 (de) 1995-11-07 1996-10-23 Verwendung von flupirtin zur prophylaxe und therapie von erkrankungen, die mit einer beeinträchtigung des hämatopoetischen zellsystems einhergehen

Publications (1)

Publication Number Publication Date
HK1016508A1 true HK1016508A1 (en) 1999-11-05

Family

ID=7776799

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99101726A HK1016508A1 (en) 1995-11-07 1999-04-21 Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment...

Country Status (27)

Country Link
US (2) US6034111A (da)
EP (1) EP0859613B1 (da)
JP (1) JPH11514652A (da)
KR (1) KR100512673B1 (da)
CN (1) CN1116037C (da)
AT (1) ATE316789T1 (da)
AU (1) AU711207B2 (da)
BG (1) BG63149B1 (da)
BR (1) BR9611588A (da)
CA (1) CA2189705C (da)
CZ (1) CZ298115B6 (da)
DE (2) DE19541405A1 (da)
DK (1) DK0859613T3 (da)
ES (1) ES2257755T3 (da)
HK (1) HK1016508A1 (da)
HU (1) HU225742B1 (da)
MX (1) MX9803610A (da)
NO (1) NO315074B1 (da)
NZ (1) NZ330414A (da)
PL (1) PL186537B1 (da)
PT (1) PT859613E (da)
RU (1) RU2200555C2 (da)
SK (1) SK284601B6 (da)
TW (1) TW393317B (da)
UA (1) UA51682C2 (da)
WO (1) WO1997017072A2 (da)
ZA (1) ZA968783B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19625582A1 (de) * 1996-06-27 1998-01-02 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
EP1688141A1 (en) * 2005-01-31 2006-08-09 elbion AG The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
DE102009023162B4 (de) * 2009-05-29 2011-07-07 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Flupirtin
CA2771090C (en) * 2009-08-07 2017-07-11 Swagelok Company Low temperature carburization under soft vacuum
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
WO2013127539A2 (de) * 2012-03-02 2013-09-06 Meda Pharma Gmbh & Co. Kg Pharmazeutische formulierungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN172468B (da) * 1990-07-14 1993-08-14 Asta Medica Ag
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin

Also Published As

Publication number Publication date
US6034112A (en) 2000-03-07
PL326629A1 (en) 1998-10-12
JPH11514652A (ja) 1999-12-14
KR19990067366A (ko) 1999-08-16
TW393317B (en) 2000-06-11
HUP9901659A2 (hu) 1999-09-28
WO1997017072A3 (de) 1997-07-24
BG102404A (en) 1998-12-30
KR100512673B1 (ko) 2005-12-09
PT859613E (pt) 2006-06-30
CZ298115B6 (cs) 2007-06-27
RU2200555C2 (ru) 2003-03-20
AU711207B2 (en) 1999-10-07
SK284601B6 (sk) 2005-07-01
NO981898D0 (no) 1998-04-27
ZA968783B (en) 1997-05-27
ES2257755T3 (es) 2006-08-01
CN1116037C (zh) 2003-07-30
BG63149B1 (bg) 2001-05-31
AU1716597A (en) 1997-05-29
HUP9901659A3 (en) 2001-04-28
CA2189705A1 (en) 1997-05-08
MX9803610A (es) 1998-09-30
SK58698A3 (en) 1998-09-09
BR9611588A (pt) 1999-04-06
CA2189705C (en) 2005-08-09
ATE316789T1 (de) 2006-02-15
PL186537B1 (pl) 2004-01-30
EP0859613A2 (de) 1998-08-26
CN1201391A (zh) 1998-12-09
DE19541405A1 (de) 1997-05-15
NO981898L (no) 1998-04-27
EP0859613B1 (de) 2006-02-01
HU225742B1 (en) 2007-07-30
DK0859613T3 (da) 2006-06-06
CZ128398A3 (cs) 1998-09-16
WO1997017072A2 (de) 1997-05-15
US6034111A (en) 2000-03-07
UA51682C2 (uk) 2002-12-16
NO315074B1 (no) 2003-07-07
NZ330414A (en) 1999-10-28
DE59611327D1 (de) 2006-04-13

Similar Documents

Publication Publication Date Title
AU586860B2 (en) Therapeutical application of phosphonylmethoxyalkyl adenines
TW371660B (en) Therapeutic nucleosides a purine carbocyclic nucleosides for treatment of HIV and HBV infections
YU18899A (sh) L-nukleozidi purina, njihovi analogoni i primena
MX9606732A (es) Compuestos terapeuticos.
IE900073L (en) Treatment of diseases associated with hiv infections
HK1016508A1 (en) Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment...
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
AP9801286A0 (en) Therapeutic compounds.
MY105855A (en) Therapeutic nucleotides.
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
NZ512850A (en) Treatment of papillomavirus infections
FR2632525B1 (fr) Application therapeutique de la myeloperoxydase humaine
AU5061090A (en) Aids therapy
MX9700560A (es) Metodo de uso de integrasa retroviral negativa transdominante en el tratamiento de infecciones retrovirales.
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
AU5535498A (en) Treatment of HIV positive patients
AU2396900A (en) Treatment and prevention of hiv and other viral infections
MD1051C2 (ro) Remediu antiherpetic
AU2211592A (en) Method of treatment for latent virus infection
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
ES8700940A1 (es) Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus
AU2450900A (en) Therapeutic nucleoside compound
AU660916B2 (en) Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours
GR1002968B (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε εναιωρημα εμβρυικων κυτταρων με ανοσοδιορθωτικη δραση και μεθοδος θεραπειας ζαχαρωδους διαβητη με τη χρηση αυτου του παρασκευασματος.
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081023